Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D1 receptor positive allosteric modulator in patients with schizophrenia.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Amit DesaiTong Zhu

Abstract

ASP4345, a novel dopamine D1 receptor positive allosteric modulator, is being evaluated for the treatment of cognitive impairment associated with schizophrenia (CIAS). This phase 1 multiple ascending-dose study (NCT02720263) assessed the safety, tolerability, and pharmacodynamics of ASP4345 in patients with schizophrenia/schizoaffective disorder. Pharmacodynamic assessments were Cogstate cognitive tests and electrophysiological biomarkers, including gamma-band power and phase synchronization in response to 40-Hz auditory steady-state stimulation, as well as mismatch negativity (MMN) and P3a event-related potentials. The sample size determination was based on standard practice in assessing safety and tolerability of a new chemical entity. Data were summarized by conversion of this data into effect sizes using descriptive and inferential statistics. A total of 36 randomized patients received ASP4345 (3, 15, 50, and 150 mg; n = 9 each dose) and 12 patients received placebo. Patients in the ASP4345 group experienced 73 treatment-emergent adverse events (TEAEs) and 34 TEAEs were reported for the placebo group. The most common TEAEs were headache and somnolence and nearly all TEAEs were mild in severity. No changes in mood or self-re...Continue Reading

References

Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M S Starr, B S Starr
May 1, 2004·Psychopharmacology·Patricia S Goldman-RakicGraham V Williams
Feb 9, 2005·Archives of General Psychiatry·Gregory A Light, David L Braff
Sep 2, 2005·The American Journal of Psychiatry·Gregory A Light, David L Braff
Mar 27, 2007·Schizophrenia Research·Michael KiangDavid L Braff
May 25, 2007·Journal of the International Neuropsychological Society : JINS·Michael KiangMarta Kutas
Jun 30, 2007·Annual Review of Neuroscience·Wolfram Schultz
Jun 4, 2010·Human Psychopharmacology·Robert H PietrzakPaul Maruff
Dec 15, 2010·Neuron·Ethan S Bromberg-MartinOkihide Hikosaka
Mar 1, 2012·Biological Psychiatry·Kenji KiriharaGregory A Light
May 23, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Anthony J RisslingGregory A Light
Jul 31, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel R RosellLarry J Siever
Jun 13, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Neal R SwerdlowGregory A Light
Mar 8, 2016·Biological Psychiatry·Amy F T ArnstenRichard B Mailman
Feb 1, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Veronica B PerezGregory A Light
Apr 21, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gregory A LightNeal R Swerdlow
Nov 1, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William C HochbergerGregory A Light
Feb 4, 2019·Trends in Cognitive Sciences·Torben Ott, Andreas Nieder
Apr 3, 2019·Nature Reviews. Drug Discovery·Mustafa SahinLaura A Mamounas
Jun 10, 2019·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Veronica B PerezGregory A Light
Sep 12, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gregory A Light, Neal R Swerdlow

❮ Previous
Next ❯

Citations

Dec 20, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daisuke KoshiyamaGregory A Light
Jul 22, 2021·ChemMedChem·Xi Khai Wong, Keng Yoon Yeong
Aug 24, 2021·Schizophrenia Bulletin·Anissa Abi-DarghamJeffrey Lieberman

❮ Previous
Next ❯

Software Mentioned

EEGlab
SAS
Matlab
BrainVision Analyzer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.